Prescribing data, metrics or supporting resources
The selection of metrics to support key therapeutic topics is overseen by the NHS England Medicines Optimisation Intelligence Group, and work is ongoing in this area. At this point, the following metrics have been identified by this group to support this topic.
In April 2015, NHS England launched a national programme to reduce inappropriate antibiotic prescribing, with incentive funding for hospitals and clinical commissioning groups (CCGs). The payments form part of 2 schemes that reward excellence and quality improvement: the Commissioning for Quality and Innovation (CQUIN) and the Quality Premium scheme. For 2016/17, a new CCG improvement and assessment framework was also launched, which includes antimicrobial resistance indicators.
CCG performance against the antimicrobial resistance quality premium and the antimicrobial resistance indicators in the CCG improvement and assessment framework is reported monthly via the NHS England Antibiotic quality premium monitoring dashboard and the national antimicrobial stewardship dashboard on ePACT2.
The Advisory Committee on Antimicrobial Prescribing, Resistance and Healthcare Associated Infection (APRHAI), which provides advice to the government on minimising the risk of healthcare associated infections, has agreed antimicrobial prescribing quality measures for primary and secondary care.
Three medicines optimisation key therapeutic topic (MO KTT) prescribing comparators are available:
Co-amoxiclav, cephalosporins & quinolones % items
3 day courses of antibiotics: ADQ/item.
The Medicines optimisation dashboard, which brings together a range of medicines-related metrics from across sectors, includes the first 2 of these comparators. The medicines optimisation dashboard helps NHS organisations to understand how well their local populations are being supported to optimise medicines use and inform local planning. The dashboard allows NHS organisations to highlight variation in local practice and provoke discussion on the appropriateness of local care. It is not intended as a performance measurement tool and there are no targets. The antibacterial items/STAR-PU comparator and the co-amoxiclav, cephalosporins & quinolones % items comparator, plus additional comparators aligned to the CCG quality premium and the CCG improvement and assessment framework, are also included in the national antimicrobial stewardship dashboard on ePACT2.